Results

Total Results: 455 records

Showing results for "neoplasms malignant neoplasm".

  1. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2009_MaskedStats_Core_Weighted.PDF
    January 01, 2009 - 14: Cancer of colon 99,870 0.25% 15: Cancer of rectum and anus 43,721 0.11% 16: Cancer of liver and … ; other and unspecified primary 7,416 0.02% 42: Secondary malignancies 217,757 0.55% 43: Malignantneoplasm without specification of site 7,909 0.02% 44: Neoplasms of unspecified nature or uncertain … behavior 49,877 0.13% 45: Maintenance chemotherapy; radiotherapy 161,999 0.41% 46: Benign neoplasm … of uterus 180,869 0.46% 47: Other and unspecified benign neoplasm 156,051 0.40% 48: Thyroid disorders
  2. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Core.PDF
    January 01, 2010 - : Cancer of uterus 7,902 0.10% 26: Cancer of cervix 3,886 0.05% 27: Cancer of ovary 5,425 0.07% 28 … : Cancer of other female genital organs 1,375 0.02% 29: Cancer of prostate 17,659 0.23% 30: Cancer … ; other and unspecified primary 1,816 0.02% 42: Secondary malignancies 46,349 0.59% 43: Malignant neoplasm … 10,271 0.13% 45: Maintenance chemotherapy; radiotherapy 38,170 0.49% 46: Benign neoplasm of uterus … 31,928 0.41% 47: Other and unspecified benign neoplasm 30,937 0.40% 48: Thyroid disorders 9,792 0.13%
  3. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Core_Weighted.PDF
    January 01, 2010 - 14: Cancer of colon 97,103 0.25% 15: Cancer of rectum and anus 42,372 0.11% 16: Cancer of liver and … ; other and unspecified primary 9,224 0.02% 42: Secondary malignancies 233,930 0.60% 43: Malignantneoplasm without specification of site 8,779 0.02% 44: Neoplasms of unspecified nature or uncertain … behavior 51,571 0.13% 45: Maintenance chemotherapy; radiotherapy 192,177 0.49% 46: Benign neoplasm … of uterus 159,867 0.41% 47: Other and unspecified benign neoplasm 156,328 0.40% 48: Thyroid disorders
  4. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2009_MaskedStats_Core.PDF
    January 01, 2009 - 14: Cancer of colon 19,725 0.25% 15: Cancer of rectum and anus 8,681 0.11% 16: Cancer of liver and … : Cancer of uterus 8,044 0.10% 26: Cancer of cervix 4,336 0.06% 27: Cancer of ovary 5,175 0.07% … ; other and unspecified primary 1,480 0.02% 42: Secondary malignancies 43,321 0.55% 43: Malignant neoplasm … 9,897 0.13% 45: Maintenance chemotherapy; radiotherapy 32,344 0.41% 46: Benign neoplasm of uterus … 36,019 0.46% 47: Other and unspecified benign neoplasm 31,084 0.40% 48: Thyroid disorders 9,092 0.12%
  5. hcup-us.ahrq.gov/reports/natstats/93drga.htm
    October 01, 1992 - disorders 8,225 0.02 11.90 14,318 & injuries 10 Nervous system neoplasms … 47,824 0.14 8.84 11,844 w/ CC 11 Nervous system neoplasms … OR procedures 64 Ear, nose, mouth & 9,229 0.03 8.30 12,244 throat malignancy … 9,679 0.03 4.22 8,778 OR procedures w/o CC 172 Digestive malignancy … 58,314 0.17 9.15 12,717 w/ CC 173 Digestive malignancy 6,313
  6. hcup-us.ahrq.gov/reports/natstats/94drga.htm
    October 01, 1992 - 17 Myeloproliferative Diseases and Disorders, and Poorly 473 Differentiated Neoplasms … w/ CC 11 Nervous system 9,011 0.03 4.69 7,677 neoplasms w/o … OR procedures 64 Ear, nose, mouth & 8,942 0.03 9.36 13,790 throat malignancy … digestive system 8,767 0.03 4.30 9,956 OR procedures w/o CC 172 Digestive malignancy … 57,362 0.17 8.48 12,746 w/ CC 173 Digestive malignancy 5,110
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/VN82XmdDhcK74WtHxWBTqm
    May 01, 2004 - Cancer Screening Incident Lung Advanced Tumors Non-resectable Mortality Rate/1,000 Cancer (No) Stage … Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin. … The Philadelphia Pulmonary Neoplasm Research Project. … Clinical features of lung cancers discovered as a postmortem “surprise.” … Percent Year Population Intervention Malignancies (%) Resectable Survival Philadelphia Neoplasm Research
  8. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core_Weighted.PDF
    January 01, 2009 - 25: Cancer of uterus <= 50 *.**% 26: Cancer of cervix <= 50 *.**% 27: Cancer of ovary 319 0.00% … 28: Cancer of other female genital organs <= 50 *.**% 29: Cancer of prostate <= 50 *.**% 30: Cancer … ; other and unspecified primary 1,985 0.03% 42: Secondary malignancies 1,939 0.03% 43: Malignant neoplasm … 0.04% 45: Maintenance chemotherapy; radiotherapy 41,364 0.56% 46: Benign neoplasm of uterus 87 0.00% … 47: Other and unspecified benign neoplasm 9,362 0.13% 48: Thyroid disorders 1,412 0.02% 49: Diabetes
  9. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Core_Weighted.PDF
    January 01, 2008 - 14: Cancer of colon 108,893 0.27% 15: Cancer of rectum and anus 46,148 0.12% 16: Cancer of liver … ; other and unspecified primary 8,477 0.02% 42: Secondary malignancies 244,962 0.61% 43: Malignantneoplasm without specification of site 6,879 0.02% 44: Neoplasms of unspecified nature or uncertain … behavior 53,573 0.13% 45: Maintenance chemotherapy; radiotherapy 182,190 0.46% 46: Benign neoplasm … of uterus 189,585 0.48% 47: Other and unspecified benign neoplasm 170,261 0.43% 48: Thyroid disorders
  10. hcup-us.ahrq.gov/reports/natstats/commdx/table1g.htm
    February 11, 2011 - Secondary malignancies [42] 18,812 25.44 0.05 … Cancer of bronchus, lung [19] 4,338 5.87 0.01 … Other and unspecified benign neoplasm [47] 10,024 14.20 0.03 … Secondary malignancies [42] 5,706 8.08 0.02 … Other and unspecified benign neoplasm [47] 17,603 25.12 0.05
  11. hcup-us.ahrq.gov/db/nation/kid/tools/stats/PublicSummaryStats_KID_2006_Core.PDF
    January 01, 2006 - 322 0.01 17: Cancer of pancreas 21 0.00 18: Cancer of other GI organs, peritoneum 255 0.01 19: Cancer … of skin 43 0.00 24: Cancer of breast 12 0.00 25: Cancer of uterus <= 10 **.** 26: Cancer of cervix … 23 0.00 27: Cancer of ovary 200 0.01 28: Cancer of other female genital organs 17 0.00 29: Cancer … 1196 0.04 42: Secondary malignancies 1260 0.04 43: Malignant neoplasm without specification of site … , radiotherapy 24803 0.79 46: Benign neoplasm of uterus 54 0.00 47: Other unspecified benign neoplasm
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/L5UwXoftg4JHw4buVDhjUT
    October 01, 2010 - tissue) tumors. … 25% present as invasive tumors (12). … invasive tumor (7). … Evidence on the natural history of asymptomatic bladder cancer is lacking because tumors are typically … tumor marker.
  13. www.uspreventiveservicestaskforce.org/home/getfilebytoken/nfQJhay7BJKbhy35DV37xK
    January 01, 2001 - , biopsies, confirmed skin cancers, and stages and thickness of skin cancers. … (Am J Prev Med 2001;20(3S): 47–58) Medical Subject Headings (MeSH): skin neoplasms, mass screening, … cancer.15,16 A large primary tumor (.2 cm) is associated with an increased risk of metastasis. … The latter study80 concluded that poor prognosis was due to rapidly growing tumors rather than delays … nodular melanoma, the type typically found in the elderly, since there is little evidence that lethal tumors
  14. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2007_MaskedStats_Core.PDF
    January 01, 2007 - cancer of skin 1435 0.02 24: Cancer of breast 19267 0.24 25: Cancer of uterus 8271 0.10 26: Cancer … 0.01 31: Cancer of other male genital organs 189 0.00 32: Cancer of bladder 7643 0.10 33: Cancer … ; other and unspecified primary 1696 0.02 42: Secondary malignancies 52442 0.65 43: Malignant neoplasm … 0.13 45: Maintenance chemotherapy; radiotherapy 37582 0.47 46: Benign neoplasm of uterus 42985 0.53 … 47: Other and unspecified benign neoplasm 33381 0.42 48: Thyroid disorders 9457 0.12 49: Diabetes
  15. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Core.PDF
    January 01, 2008 - : Cancer of uterus 8,666 0.11% 26: Cancer of cervix 4,520 0.06% 27: Cancer of ovary 5,561 0.07% 28 … : Cancer of other female genital organs 1,511 0.02% 29: Cancer of prostate 22,067 0.27% 30: Cancer … ; other and unspecified primary 1,729 0.02% 42: Secondary malignancies 50,158 0.61% 43: Malignant neoplasm … 10,933 0.13% 45: Maintenance chemotherapy; radiotherapy 37,467 0.46% 46: Benign neoplasm of uterus … 39,046 0.48% 47: Other and unspecified benign neoplasm 34,825 0.43% 48: Thyroid disorders 10,323 0.13%
  16. hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-User-Guide-v2025-1.pdf
    November 01, 2024 - status, and Z19.2, Hormone resistant malignancy status, to CCSR category NEO071 (Malignant neoplasmNeoplasms NEO NEO contains 78 categories specific to neoplasms, which include malignant neoplasms … such as gastrointestinal cancers, skin cancers, and breast cancer, as well as most benign neoplasms … The Neoplasms body system follows the National Cancer Institute (NCI)8 organization of cancer types … status, and Z19.2, Hormone resistant malignancy status, to CCSR category NEO071 (Malignant neoplasm
  17. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Core.PDF
    January 01, 2006 - Cancer of colon 21939 0.27 15: Cancer of rectum and anus 9066 0.11 16: Cancer of liver and intrahepatic … of skin 1186 0.01 24: Cancer of breast 17356 0.21 25: Cancer of uterus 7861 0.10 26: Cancer of cervix … 32: Cancer of bladder 7911 0.10 33: Cancer of kidney and renal pelvis 9114 0.11 34: Cancer of other … , other Unspecified primary 1542 0.02 42: Secondary malignancies 49508 0.61 43: Malignant neoplasmneoplasm of uterus 42394 0.53 47: Other unspecified benign neoplasm 33896 0.42 48: Thyroid disorders
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
    February 22, 2012 - and Endobronchial Obstruction Due to Advanced Lung Tumors I. … recurrence, noncancer-related mortality, and second malignancies.2, 3 Malignant Endobronchial Obstruction … Intraoperative seed placement for thoracic malignancy-A review of technique, indications, and published … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non- small-cell' OR 'non-small cell' OR 'non … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non- small-cell' OR 'non-small cell' OR 'non
  19. hcup-us.ahrq.gov/db/nation/kid/tools/stats/PublicSummaryStats_KID_2006_Severity.PDF
    January 01, 2006 - electrolyte disorders 3131324 0 0.00 1.00 0.08 0.27 CM_METS : AHRQ comorbidity measure: Metastatic cancer … WO CC 463 0.01 101: NERVOUS SYSTEM NEOPLASMS W CC 631 0.02 102: NERVOUS SYSTEM NEOPLASMS W MCC 123 … WO CC 81 0.00 821: RESPIRATORY NEOPLASMS W CC 116 0.00 822: RESPIRATORY NEOPLASMS W MCC 43 0.00 830 … WO CC 234 0.01 3031: KIDNEY & URETER PROCS NEOPLASM W CC 201 0.01 3032: KIDNEY & URETER PROCS NEOPLASM … WO CC 62 0.00 3181: KIDNEY & URINARY TRACT NEOPLASMS W CC 66 0.00 3182: KIDNEY & URINARY TRACT NEOPLASMS
  20. hcup-us.ahrq.gov/datainnovations/ICD-10_DXCCS_Trends112817.pdf
    November 28, 2017 - 0.8 –2.9 43: Malignant neoplasm without specification of site 1,064 1,072 1,308 0.8 22.0 44: … 18,167 22,433 8.4 23.5 43: Malignant neoplasm without specification of site 4,728 4,931 3,062 4.3 … 45: Maintenance chemotherapy; radiotherapy 500 606 834 21.2 37.6 46: Benign neoplasm of uterus … 15,610 17,381 17,512 11.3 0.8 47: Other and unspecified benign neoplasm 20,852 23,784 22,214 14.1 … of pancreas 2,592 2,994 3,019 15.5 0.8 46: Benign neoplasm of uterus 15,610 17,381 17,512 11.3 0.8

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive